Pro Medicus Ltd
PME
Company Profile
Business description
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
Contact
450 Swan Street
RichmondVIC3121
AUST: +61 394298800
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2025
Employees
75
Stocks News & Analysis
stocks
Should you avoid this highflying ASX share?
A sound business model but the shares are expensive.
personal-finance
Bookworm: A timely reminder of what can drive a market reversal
David Dreman sought to beat the market by going against the crowd. The mechanisms behind that could explain Nvidia's recent fall.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,125.20 | 111.50 | 1.39% |
| CAC 40 | 7,482.36 | 155.89 | 2.13% |
| DAX 40 | 21,961.97 | 668.44 | 3.14% |
| Dow JONES (US) | 39,606.57 | 419.59 | 1.07% |
| FTSE 100 | 8,403.18 | 74.58 | 0.90% |
| HKSE | 22,072.62 | 510.30 | 2.37% |
| NASDAQ | 16,708.05 | 407.63 | 2.50% |
| Nikkei 225 | 34,868.63 | 648.03 | 1.89% |
| NZX 50 Index | 11,956.47 | 119.78 | 1.01% |
| S&P 500 | 5,375.86 | 88.10 | 1.67% |
| S&P/ASX 200 | 7,920.50 | 103.80 | 1.33% |
| SSE Composite Index | 3,296.36 | 3.40 | -0.10% |